Journal of Diabetes

Cover image for Vol. 7 Issue 3

Edited By: Zachary T. Bloomgarden and Guang Ning

Impact Factor: 2.349

ISI Journal Citation Reports © Ranking: 2013: 73/124 (Endocrinology & Metabolism)

Online ISSN: 1753-0407



Author Guidelines


1. MANUSCRIPT SUBMISSION

Thank you for your interest in Journal of Diabetes. Please read the complete Author Guidelines carefully prior to submission, including the section on copyright and page charges. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.

Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://mc.manuscriptcentral.com/jdb.

We are looking forward to your submission.

2. EDITORIAL CONSIDERATIONS

Aims and Scope
Journal of Diabetes (JDB) devotes itself to diabetes research, therapeutics, and education. It aims to involve researchers and practitioners in a dialogue between East and West via all aspects of epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. The Editorial team is international with a unique mix of Asian and Western participation. The Journal has established a specific "Asia Track" to further this endeavor by bringing to the international community articles which focus on aspects of diabetes of particular relevance to Asia.

The Editors welcome submissions in form of original research articles, images, novel case reports and correspondence, and we solicit reviews, point-counterpoint, commentaries, editorials, news highlights, and educational content.

Review Process

Manuscripts are assigned sequentially to Associate Editors. An Associate Editor solicits reviewers (typically, two external reviews are sought). The reviewers’ evaluations and Associate Editor’s comments are compiled by the Editor-in-Chief for disposition and transmittal to the authors. A decision is made usually within six weeks of the receipt of the manuscript.

The Editor-in-Chief will advise authors whether a manuscript is accepted, should be revised or is rejected. Minor revisions are expected to be returned within four weeks of decision; major revisions within three months. Manuscripts not revised within these time periods are subject to withdrawal from consideration for publication unless the authors can provide extenuating circumstances.

A number of manuscripts will have to be rejected on the grounds of priority and available space. A manuscript may be returned to the authors without outside review if the Editor-in-Chief and Associate Editor find it inappropriate for publication in the Journal. Similarly, the Editors may expedite the review process for manuscripts felt to be of high priority in order to reach a rapid decision. Such ‘fast-track decisions’ will normally occur within one week of receipt of the manuscript.

Authors shall provide the Editor-in-Chief with the names, addresses and email addresses of up to three suitably qualified individuals of international standing who would be competent to referee the work, although the Editor-in-Chief will not be bound by any such nomination. Likewise, authors may advise of any individual who for any reason, such as potential conflict of interest, might be inappropriate to act as a referee, again without binding the Editor-in-Chief.

The Editor-in-Chief’s decision is final. If, however, authors dispute a decision and can document good reasons why a manuscript should be reconsidered, a rebuttal process exists. In the first place, authors should write to the Editor-in-Chief.

3. ETHICAL CONSIDERATIONS

Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and i) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

Disclosure
At the time of submission, the submitting author must include a disclosure statement in the body of the manuscript. All authors are required to disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. This information should be provided under the heading titled ‘Disclosure,’ which should appear after the ‘Acknowledge’ section and before the ‘References’ section. Authors without conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject of their manuscript, should include a statement of no such interests in the Disclosure section of the manuscript. Failure to include this information in the manuscript may delay evaluation and review of the manuscript. The conflict of interest policy for the Editors is available on the home page.

Principles for Publication of Research Involving Human Subjects
Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used).

In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.

Any experiments involving animals must be demonstrated to be ethically acceptable and must conform to international guidelines for animal usage in research, such as those of the US NIH or the UK Home Office.

Clinical Trials Registry
We require, as a condition of consideration for publication, registration in a public trials registry. Trials must register at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after January 1, 2006. For trials that began enrollment before this date, we require registration by April 1, 2006, before considering the trial for publication. We define a clinical trial as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials) are exempt.

We do not advocate one particular registry, but registration must be with a registry that meets the following minimum criteria: (1) accessible to the public at no charge; (2) searchable by standard, electronic (Internet-based) methods; (3) open to all prospective registrants free of charge or at minimal cost; (4) validates registered information; (5) identifies trials with a unique number; and (6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that currently meet these criteria include: (1) the registry sponsored by the United States National Library of Medicine; (2) the International Standard Randomized Controlled Trial Number Registry; (3) the Australian New Zealand Clinical Trials Registry (ANZCTR); (4) the Chinese Clinical Trials Register; and (5) the Clinical Trials Registry - India.

Randomized control trials
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement.

Reproduction of Copyright Material. If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html

Plagiarism Detection. The journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Committee on Publication Ethics. The journal is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).

4. MANUSCRIPT CATEGORIES

(1) Original Articles
Word limit: 4,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, with sub-headers.
References: no limit.
Figures/ tables: no limit, but 8 figures should be sufficient.
Description: Full-length reports of current research in either basic or clinical science.

(2) Case Reports
Word limit: 1,000 words maximum including abstract but excluding references, tables and figures.
Abstract: no abstract required for this manuscript type.
References: no limit.
Figures/ tables: 4 maximum.
Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in diabetes. The text should be arranged as follows: Introduction; Case Report; Discussion. Such cases would be expected to illustrate highly unusual demonstrations of diabetes-related principals, such as genetic or hormonal variations, which would not be expected to occur with sufficient frequency to be demonstrable in the setting of a clinical trial or population study.

(3) Point Counter-Point [by invitation of Editors]
Title: 10 words maximum.
Word limit: 700 words maximum.
Abstract: not required for this manuscript type.
Figures/ tables: 4 maximum.
References: 8 maximum.
Figures: 2 maximum.
Description: Balanced discussion of controversies in pathology.

(4) Letters to the Editor
Word limit: 500 words maximum.
Abstract: not required for this manuscript type.
References: 5 maximum.
Figures/ tables: 1 maximum.
Description: Letters must offer perspective to content published in JDB. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.

Commentaries [by invitation of Editors]
Word limit: 1,500 words maximum including abstract but excluding references.
Title: 20 words maximum.
References: 20 maximum, including the article discussed.
Figures/tables: 2 maximum.
Description: Commentaries discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider con-text of the field.

(6) Review Articles
Word limit: 5,000 words maximum including abstract but excluding references, tables and figures.
Abstract: 250 words maximum.
References: no maximum.
Figures/tables: minimum 1 image or figure.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

(7) Research Letters
Word limit: 800 words maximum
Abstract: none
References: 8 maximum
Figures/tables: 2 maximum.
Authors: 5 maximum; Other persons who have contributed to the study may be indicated in an Acknowledgement with their permission, including their academic degrees, affiliations, contribution to the study, and an indication if compensation was received for their role.
Description: Research Letters should report original findings in an intermediate fashion between an abstract and an article. These submissions must not duplicate other material published or submitted for publication. In general, Research Letters should be divided into the following sections: To the Editor (which serves an introduction), Methods, Results, and Comment. Research Letters considered for publication will undergo peer review.

(8) Editorials [by invitation of Editors]
Word Limit: 1,500 words maximum.
Abstract: no abstract required for this manuscript type.
References: 5 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

(9) Rapid Publication
Word limit: 700 words maximum.
Abstract: no abstract required for this manuscript type.
References: 8 maximum.
Figures: 2 maximum.
Description: Rapid Communications are intended to disseminate information as quickly as possible due to the new research and information presented. They undergo one review only and no revisions are al-lowed unless very minor.

(10) Diabetes News [by invitation of Editors]
Word limit: 500 words maximum.
Abstract: no abstract required for this manuscript type.
References: 5 maximum.
Figures: 2 maximum.
Proposals for Diabetes News may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

5. PREPARATION OF THE MANUSCRIPT

Pre-acceptance English-language editing
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit our site to learn about the options. All services are paid for and arranged by the author.  Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.

Optimising Your Article for Search Engines
Many students and researchers looking for information online will use search engines such as Google, Yahoo or similar. By optimising your article for search engines, you will increase the chance of someone finding it. This in turn will make it more likely to be viewed and/or cited in another work. We have compiled these guidelines to enable you to maximise the web-friendliness of the most public part of your article.

Style of the Manuscript
Manuscripts must follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication.

Author name: Each author’s name should be put in the following order:
First and Middle names (given name, capitalize the first letter of each name)
Last name (family name, surname, all letters should be capitalized)

Spelling: The journal uses US spelling and authors should therefore follow the latest edition of Merriam–Webster’s Collegiate Dictionary.

Units: All measurements must be given in SI or SI-derived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website.

Abbreviations: Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names: Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures; and supplementary files if required. As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors.

Title Page File
The title page should contain (i) the title and running title (less than 40 characters) of the paper. Concise titles are easier to read than long, convoluted ones. Titles that are too short may, however, lack important information, such as study design (which is particularly important in identifying randomized controlled trials). Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific. (ii) the full names of the authors (for details on how to present the Author names see the section on Style of the Manuscript) and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent, and note that only one corresponding author is permitted. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote. The title should be short, informative and contain the major key words so that readers and in particular online users will discover the article easily in online search. In general, abbreviations should not be used in the title.

Main Text File
The main text file should be presented in the following order: (i) Abstract, (ii) Key points, (iii) Key words (iv) Text, (v) Acknowledgments, (vi) Disclosure, (vii) References, (viii) Tables (each table complete with title and footnotes), and (ix) figure legends. Figures and supplementary material should be supplied as separate files.

Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

Abstract
The length of abstracts must adhere to the word count specifications under the section Manuscript Categories. Original article abstracts should be structured using the following subheadings: Background, Methods, Results, and Conclusions. Other manuscript types do not require structured abstracts and therefore do not require subheadings.Abstracts must be factual and comprehensive. The use of abbreviations and acronyms should be limited and general statements (e.g. ‘‘the significance of the results is discussed’’) should be avoided.

Key points
For Original Articles authors are required to individually list and provide responses to the following two questions about the significant findings of the study, using a maximum of 40 words for each answer:
• Significant findings of the study
• What this study adds

Keywords
Three to five key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list.

Text
Authors must use the following subheadings to divide the sections of their Original Article manuscript: Introduction, Methods, Results, Discussion.

Acknowledgements
This should include sources of support/funding, including federal and industry support. All authors who have contributed to the manuscript must be acknowledged any federal and industry support/funding received. Medical writers, proofreaders and editors should not be listed as authors, but acknowledged here in the acknowledgements section.

Disclosure
All articles are required to include a disclosure statement. The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. Authors without conflicts of interest should include a statement of no such interests in the Disclosure section of the manuscript. This information should be provided under the heading titled ‘Disclosure,’ which should appear after the ‘Acknowledge’ section and before the ‘References’ section. Failure to include this information in the manuscript may delay evaluation and review of the manuscript. The journal also has an Editorial Conflict of Interest Policy available for viewing via the journal home page.

References
The Vancouver system of referencing should be used (examples are given below). In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first three followed by et al. Do NOT use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list. Names of journals should be abbreviated in the style used in Index Medicus. Authors are responsible for the accuracy of the references.

• Journal Article
1. Gibas Z, Prout DF Jr, Pontes JR. Chromosome changes in germ cell tumours of the testis. Cancer Genet Cytogenet. 1986; 19: 254-62.

• Online article not yet published in an issue
An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can e-cited by its Digital Object Identifier(DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.
3. Kengne Ap, Nakamura K, Barzi F, et al. Smoking , Diabetes and cardiovascular diseases in men in the Asia=Pacific Region. J Diabetes 2009; doi: 10.1111/j.1753-0407.2009.00028.x

• Book
3. Ernstoff M. Urologic Cancer. Blackwell Science, Boston, 1997.

• Chapter in a Book
4. Gilchrist RK. Further commentary: Continent stroma. In: King LR, Stone AR, Webster GD (eds). Bladder Reconstruction and Continent Urinary Diversion. Year Book Medical, Chicago, 1987; 204-5.

Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure legends
Type figure legends on a separate page after References or Tables if the manuscript includes them. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration.

• Size - Figures should be sized to fit within the column (82mm), intermediate (118mm) or the full text width (173mm).

• Text sizing in figures - Lettering must be included and should be sized to be no larger than the journal text or 8 point (Should be readable after reduction – avoid large type or thick lines). Line width between 0.5 and 1 point.

Preparation of Electronic Figures for Publication: Although low quality images are adequate for review purposes, publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented programmes. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.

More advice on figures can be found at Wiley’s guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp

Supporting Information
Supporting information is not essential to the article but provides greater depth and background and may include tables, figures, videos, datasets, etc. This material can be submitted with your manuscript, and will appear online, without editing or typesetting. Guidelines on how to prepare this material and which formats and files sizes are acceptable can be found at: http://authorservices.wiley.com/bauthor/suppmat.asp

Please note that the provision of supporting information is not encouraged as a general rule. It will be assessed critically by reviewers and editors and will only be accepted if it is essential.

6. SUBMISSION REQUIREMENTS

Manuscripts must be submitted online at: http://mc.manuscriptcentral.com/jdb

A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.

The cover letter must contain: i) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium; ii) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in; iii) a statement confirming that all authors are in agreement with the content of the manuscript

Two Word-files need to be included upon submission: A title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.

The main text file should be prepared using Microsoft Word using 1.5 line spacing. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.

Each figure should be supplied as a separate file, with the figure number incorporated in the file name and also showing within the figure. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required - see the section 'Preparing Electronic Figures for Publication' for details.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. More details on the copyright and licencing options for the journal appear below.

Wiley’s Author Services: Tracking your paper’s progress
Author Services also enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Visit http://www.authorservices.wiley.com/bauthor/eachecklist.asp for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Accepted Articles
The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After print publication, the DOI remains valid and can continue to be used to cite and access the article. The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance. Given that copyright licensing is a condition of publication, a completed copyright form is required before a manuscript can be processed as an Accepted Article. Accepted articles will be indexed by PubMed; therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.

Proofs
Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author.

Early View
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.

Offprints
A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: http://offprint.cosprinters.com/cos. If you have queries about offprints please e-mail: offprint@cosprinters.com.

Author Marketing Toolkit
The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.

8. COPYRIGHT, LICENSING AND ONLINE OPEN

Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.

Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.

Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.

Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.

OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.

Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.

9. STUDY DESIGN SUPPORT
Study Design Support is a free and confidential service by the editorial team at Journal of Diabetes to help you design your studies.

How does it work?
Our editorial team provides you with free and confidential feedback on your study design before you submit your final study to a journal, or before you do the study. Study Design Support does not reject, accept or publish your study design. We just provide you with free and confidential feedback. You submit your study design to us, using a submission form.

How long does the feedback take?
The Editors try to complete feedback on your study designs within two weeks.

Do I have to publish later in Journal of Diabetes if I use Study Design Support?
No. Journal of Diabetes welcomes manuscripts, but submission of your study design to Study Design Support does not condition and does not guarantee publication of a later and related manuscript to the Journal. Instead, Study Design Support just provides you with free and confidential feedback on your study design in advance of submission to any journal. You are free to publish your final manuscript in any journal of your own choice. Read more here.

10. EDITORIAL OFFICE

Ms Imelda Lee, Editorial Assistant
Room 1504, Science and Education Plaza
Ruijin Hospital, 197 Ruijin 2nd Road
Shanghai 200025, China

Email: editor@jdiabetes.com
Tel: +86 21 64370045 extn 611566
Fax: +86 21 64151361

Guidelines updated 27 May 2015

SEARCH

SEARCH BY CITATION